XML 42 R27.htm IDEA: XBRL DOCUMENT
v3.20.4

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables) | 9 Months Ended
--- | ---
Dec. 26, 2020
Segment Reporting [Abstract] |
Selected Information by Business Segment | Selected information by reportable segment is presented below:
| Three Months Ended |  | Nine Months Ended
(In thousands) | December 26, 2020 |  | December 28, 2019 |  | December 26, 2020 |  | December 28, 2019
Net revenues |  |  |  |  |  |  |
Plasma | $ | 102,154 |  |  | $ | 120,997 |  |  | $ | 249,587 |  |  | $ | 348,141 |
Blood Center | 80,417 |  |  | 85,314 |  |  | 234,446 |  |  | 246,977 |
Hospital | 52,334 |  |  | 50,753 |  |  | 148,927 |  |  | 147,602 |
Net revenues by business unit | 234,905 |  |  | 257,064 |  |  | 632,960 |  |  | 742,720 |
Service (1) | 4,972 |  |  | 5,197 |  |  | 15,396 |  |  | 15,339 |
Effect of exchange rates | 494 |  |  | (3,291) |  |  | (2,922) |  |  | (8,072) |
Net revenues | $ | 240,371 |  |  | $ | 258,970 |  |  | $ | 645,434 |  |  | $ | 749,987 |
(1) Reflects revenue for service, maintenance and parts |  |  |  |
| Three Months Ended |  | Nine Months Ended
(In thousands) | December 26, 2020 |  | December 28, 2019 |  | December 26, 2020 |  | December 28, 2019
Segment operating income |  |  |  |  |  |  |
Plasma | $ | 52,673 |  |  | $ | 59,343 |  |  | $ | 129,846 |  |  | $ | 169,844 |
Blood Center | 36,424 |  |  | 42,197 |  |  | 108,926 |  |  | 121,124 |
Hospital | 22,430 |  |  | 20,593 |  |  | 61,672 |  |  | 60,360 |
Segment operating income | 111,527 |  |  | 122,133 |  |  | 300,444 |  |  | 351,328 |
Corporate expenses (1) | (63,202) |  |  | (63,080) |  |  | (185,005) |  |  | (188,363) |
Effect of exchange rates | 4,286 |  |  | 2,521 |  |  | 8,644 |  |  | 7,791 |
Deal amortization | (7,805) |  |  | (5,772) |  |  | (24,204) |  |  | (17,681) |
Restructuring and turnaround costs | (3,143) |  |  | (7,798) |  |  | (11,583) |  |  | (13,582) |
Transaction costs | — |  |  | — |  |  | (3,063) |  |  | — |
PCS2 accelerated depreciation and related costs | (1,146) |  |  | (6,649) |  |  | (3,332) |  |  | (18,708) |
European Medical Device Regulation costs and other | (1,207) |  |  | (448) |  |  | (2,696) |  |  | (304) |
Impairment of assets and other related charges | — |  |  | — |  |  | (896) |  |  | (51,220) |
Gains on divestitures and sale of assets | 1,115 |  |  | — |  |  | 32,613 |  |  | 8,083 |
Operating income | $ | 40,425 |  |  | $ | 40,907 |  |  | $ | 110,922 |  |  | $ | 77,344 |
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.
Schedule of Revenues by Product Line and Geographic Regions | Management reviews revenue based on the reportable segments noted above. Although these reportable segments are primarily product-based, they differ from the Company’s product line revenues for Plasma products and services and Blood Center products and services. Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes. Additionally, product line revenues also include service revenues which are excluded from the reportable segments. Net revenues by product line are as follows:
| Three Months Ended |  | Nine Months Ended
(In thousands) | December 26, 2020 |  | December 28, 2019 |  | December 26, 2020 |  | December 28, 2019
Plasma products and services | $ | 123,510 |  |  | $ | 141,231 |  |  | $ | 309,933 |  |  | $ | 406,825 |
Blood Center products and services | 62,787 |  |  | 66,126 |  |  | 182,687 |  |  | 191,648 |
Hospital products and services | 54,074 |  |  | 51,613 |  |  | 152,814 |  |  | 151,514 |
Net revenues | $ | 240,371 |  |  | $ | 258,970 |  |  | $ | 645,434 |  |  | $ | 749,987 |
Net revenues generated in the Company's principle operating regions on a reported basis are as follows:
| Three Months Ended |  | Nine Months Ended
(In thousands) | December 26, 2020 |  | December 28, 2019 |  | December 26, 2020 |  | December 28, 2019
United States | $ | 147,607 |  |  | $ | 167,238 |  |  | $ | 382,600 |  |  | $ | 485,493 |
Japan | 20,854 |  |  | 19,268 |  |  | 57,330 |  |  | 55,111 |
Europe | 41,874 |  |  | 40,984 |  |  | 123,541 |  |  | 115,811 |
Asia | 29,050 |  |  | 29,436 |  |  | 77,602 |  |  | 88,269 |
Other | 986 |  |  | 2,044 |  |  | 4,361 |  |  | 5,303 |
Net revenues | $ | 240,371 |  |  | $ | 258,970 |  |  | $ | 645,434 |  |  | $ | 749,987 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration